DEMENTIA MODERATE
Clinical trials for DEMENTIA MODERATE explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA MODERATE trials appear
Sign up with your email to follow new studies for DEMENTIA MODERATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could flickering lights and tones slow Alzheimer's? major trial underway
Disease control OngoingThis study tests a device that delivers light and sound stimulation to people with mild to moderate Alzheimer's disease. About 670 participants will use either the active device or a sham (inactive) device for one hour daily over 12 months. The goal is to see if the stimulation c…
Matched conditions: DEMENTIA MODERATE
Phase: NA • Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 03:38 UTC
-
New pill aims to slow Alzheimer's decline in major trial
Disease control OngoingThis study tests whether a daily pill called Xanamem can safely help people with mild or moderate Alzheimer's dementia. About 247 adults aged 50 and older will receive either Xanamem or a placebo for 36 weeks, with an option to continue treatment for up to 108 weeks. The goal is …
Matched conditions: DEMENTIA MODERATE
Phase: PHASE2, PHASE3 • Sponsor: Actinogen Medical • Aim: Disease control
Last updated May 15, 2026 11:54 UTC